By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Capricor Therapeutics, Inc. 

8700 Beverly Boulevard
Davis Building - Room D-1063
Los Angeles  California  90048  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Capricor Therapeutics, Inc. Announces Positive Six-Month Results From The Randomized Phase I/II HOPE Clinical Trial In Duchenne Muscular Dystrophy 4/25/2017 6:28:03 AM
Capricor Therapeutics, Inc. Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update 3/16/2017 11:23:42 AM
Capricor Therapeutics, Inc. To Hold Fourth Quarter And Full Year 2016 Financial Results And Corporate Update Conference Call On Wednesday, March 15 3/7/2017 11:13:20 AM
Capricor Therapeutics, Inc. Terminates Natriuretic Peptide Program Deal With The Mayo Clinic 2/17/2017 9:44:56 AM
Capricor Therapeutics, Inc. Reports Third Quarter 2016 Financial Results And Provides Corporate Update 11/14/2016 11:06:22 AM
Capricor Therapeutics, Inc. Announces Plans To Expand Clinical Development Program In Duchenne Muscular Dystrophy To Evaluate Peripheral And Respiratory Muscle Function 11/11/2016 11:11:25 AM
Capricor Therapeutics, Inc. To Hold Third Quarter 2016 Business Update And Financial Results Conference Call And Webcast On Thursday, November 10 At 5:00 P.M. ET 11/3/2016 10:51:24 AM
Capricor Therapeutics, Inc. Presents Positive 12-Month Results From DYNAMIC At TCT 2016 10/31/2016 7:29:29 AM
Capricor Therapeutics, Inc. Awarded Up To $4.2 Million From NIH To Evaluate Exosomes For Hypoplastic Left Heart Syndrome 10/20/2016 8:25:50 AM
Capricor Therapeutics, Inc. Completes Enrollment In Phase II ALLSTAR Clinical Trial 10/5/2016 6:39:08 AM
12345678910
//-->